Shufersal - Public Comps and Valuation Multiples

Shufersal Overview

About Shufersal

Shufersal Ltd is a supermarket chain operator. The company is based in Israel and generates all revenue domestically. Shufersal has three operating segments: retail segment, real estate segment, and Be segment. The retail segment, which contributes the largest portion of revenue, operates neighborhood and regional food stores, a group of organic food stores, and engages in the marketing, manufacture, and sale of both frozen and fresh baked products. The real estate segment includes leasing of various commercial and other properties. The Be segment includes operation of drug stores that mainly sell cosmetics, convenience, and toiletry products. A vast majority of the company’s revenue is generated by the retail segment.

Founded

1958

HQ

Employees

14K+

Website

shufersal.co.il

Sectors

Supermarkets
Department Stores

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$3.7B

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Shufersal Financials

Shufersal has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Shufersal achieved revenue of $4.2B and an EBITDA of $587M.

Shufersal expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Shufersal valuation multiples based on analyst estimates

Shufersal P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$4.1B	$4.2B	XXX	XXX	XXX
Gross Profit	$1.1B	$1.1B	XXX	XXX	XXX
Gross Margin	26%	26%	XXX	XXX	XXX
EBITDA	$461M	$587M	XXX	XXX	XXX
EBITDA Margin	11%	14%	XXX	XXX	XXX
Net Profit	$0.3M	$84.6M	XXX	XXX	XXX
Net Margin	0%	2%	XXX	XXX	XXX
Net Debt	$528M	$457M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Shufersal Stock Performance

As of April 15, 2025, Shufersal's stock price is ILS 35 (or $9).

Shufersal has current market cap of ILS 9.2B (or $2.5B), and EV of ILS 13.7B (or $3.7B).

See Shufersal trading valuation data

Shufersal Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$3.7B	$2.5B	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Shufersal Valuation Multiples

As of April 15, 2025, Shufersal has market cap of $2.5B and EV of $3.7B.

Shufersal's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Shufersal's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Shufersal and 10K+ public comps

Shufersal Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$3.7B	XXX	XXX	XXX
EV/Revenue	0.9x	XXX	XXX	XXX
EV/EBITDA	6.3x	XXX	XXX	XXX
P/E	14.1x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	7.3x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Shufersal Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Shufersal Valuation Multiples

Shufersal's NTM/LTM revenue growth is n/a

Shufersal's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Shufersal's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Shufersal's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Shufersal and other 10K+ public comps

Shufersal Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	3%	XXX	XXX	XXX	XXX
EBITDA Margin	14%	XXX	XXX	XXX	XXX
EBITDA Growth	27%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$0.3M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	5%	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	0%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	22%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry